HIV/AIDS Vaccine Trial in Entebbe, Uganda
Cooperation between the Uganda Virus Research Institute (UVRI), the International AIDS Vaccine Initiative (IAVI) and Targeted Genetics
08-Feb-2006 -
Targeted Genetics Corporation, The Uganda Virus Research Institute (UVRI), and the International AIDS Vaccine Initiative (IAVI) announced the start of a Phase II clinical trial in Uganda to evaluate the safety and immunogenicity of tgAAC09, a preventive HIV/AIDS vaccine. This is the second ...
AIDS
clinical trials
HIV
+3